Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
09/07/2026 21:58
BRIEF-Rani Therapeutics Announces R&D Collaboration With PegBio July 9 (Reuters) - Rani Therapeutics Holdings Inc RANI.O:
ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH PEGBIO TO EXPAND OBESITY PIPELINE ACROSS MULTIPLE NOVEL CANDIDATES
CO AND PEGBIO TO DEVELOP RANIPILL FORMULATIONS FOR MULTIPLE OBESITY CANDIDATES
Source text: ID:nGNX3HtsyQ
Further company coverage: RANI.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition